Trade Summary

5 days ago, Lippoldt Darin, serving as Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 10,000 shares at $170.15 per share, for a total transaction value of $1,701,492.09. Following this transaction, Lippoldt Darin now holds 54,729 shares of NBIX.

This sale represents a 15.45% decrease in Lippoldt Darin's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 4:52 PM ET, 4 days after the trade was made.

NEUROCRINE BIOSCIENCES INC operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.